{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T12:56:38Z","timestamp":1783083398247,"version":"3.54.6"},"reference-count":60,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T00:00:00Z","timestamp":1507593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.ajog.2017.10.003","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T08:01:32Z","timestamp":1507881692000},"page":"684.e1-684.e17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Altered angiogenesis as a common mechanism underlying preterm birth, small for gestational age, and stillbirth in women living with HIV"],"prefix":"10.1016","volume":"217","author":[{"given":"Andrea L.","family":"Conroy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe R.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel L.","family":"Gamble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Olwoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Natureeba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Cohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses R.","family":"Kamya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane V.","family":"Havlir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Dorsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Kain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2017.10.003_bib1","series-title":"Global summary of the AIDS epidemic","year":"2015"},{"key":"10.1016\/j.ajog.2017.10.003_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/infdis\/jiu393","article-title":"HIV protease inhibitor use during pregnancy is associated with decreased progesterone levels, suggesting a potential mechanism contributing to fetal growth restriction","volume":"211","author":"Papp","year":"2015","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ajog.2017.10.003_bib3","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/infdis\/jis553","article-title":"Highly\u00a0active antiretroviral therapy and adverse\u00a0birth outcomes among HIV-infected women in Botswana","volume":"206","author":"Chen","year":"2012","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ajog.2017.10.003_bib4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/sti.2008.032300","article-title":"Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conception","volume":"85","author":"Machado","year":"2009","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.ajog.2017.10.003_bib5","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1097\/QAD.0b013e32830b8ab9","article-title":"Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Cote d'Ivoire","volume":"22","author":"Ekouevi","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.ajog.2017.10.003_bib6","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S0140-6736(02)11195-0","article-title":"Pre-eclampsia, antiretroviral therapy, and\u00a0immune reconstitution","volume":"360","author":"Wimalasundera","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2017.10.003_bib7","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/QAD.0b013e328133884b","article-title":"Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland","volume":"21","author":"Townsend","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.ajog.2017.10.003_bib8","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/infdis\/jir307","article-title":"Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy","volume":"204","author":"Powis","year":"2011","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ajog.2017.10.003_bib9","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/COH.0b013e3283632b88","article-title":"Safety of antiretroviral drugs in pregnancy and breastfeeding for mother and child","volume":"8","author":"Newell","year":"2013","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.ajog.2017.10.003_bib10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/QAD.0b013e32834f3232","article-title":"Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newborn","volume":"26","author":"Hernandez","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.ajog.2017.10.003_bib11","doi-asserted-by":"crossref","first-page":"e172222","DOI":"10.1001\/jamapediatrics.2017.2222","article-title":"Comparative safety of antiretroviral treatment regimens in pregnancy","volume":"171","author":"Zash","year":"2017","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.ajog.2017.10.003_bib12","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s10461-009-9537-y","article-title":"A\u00a0systematic review of factors influencing fertility desires and intentions among people living with HIV\/AIDS: implications for policy and service delivery","volume":"13","author":"Nattabi","year":"2009","journal-title":"AIDS Behav"},{"key":"10.1016\/j.ajog.2017.10.003_bib13","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/tmi.12858","article-title":"Placental pathology in HIV infection at term: a comparison with HIV-uninfected women","volume":"22","author":"Kalk","year":"2017","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.ajog.2017.10.003_bib14","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1210\/jc.2002-020195","article-title":"Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-a, angiopoietin-1, and angiopoietin-2","volume":"87","author":"Geva","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2017.10.003_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.placenta.2003.10.004","article-title":"Aspects of human fetoplacental vasculogenesis and angiogenesis, I: molecular regulation","volume":"25","author":"Charnock-Jones","year":"2004","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2017.10.003_bib16","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2017.10.003_bib17","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0002-9440(10)62567-9","article-title":"Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome","volume":"160","author":"Zhou","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajog.2017.10.003_bib18","doi-asserted-by":"crossref","first-page":"c43","DOI":"10.1159\/000101483","article-title":"Elevated serum sFlt-1\/Ang-2 ratio in women with preeclampsia","volume":"106","author":"Hirokoshi","year":"2007","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.ajog.2017.10.003_bib19","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2017.10.003_bib20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejogrb.2013.05.021","article-title":"Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia","volume":"170","author":"Govender","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2017.10.003_bib21","doi-asserted-by":"crossref","first-page":"287.e1","DOI":"10.1016\/j.ajog.2013.01.016","article-title":"Maternal plasma concentrations of angiogenic\/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia","volume":"208","author":"Chaiworapongsa","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.10.003_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14767050701830480","volume":"21","author":"Romero","year":"2008","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2017.10.003_bib23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/uog.7491","article-title":"Plasma soluble endoglin concentration in pre-eclampsia is associated with an increased impedance to flow in the maternal and fetal circulations","volume":"35","author":"Chaiworapongsa","year":"2010","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.10.003_bib24","doi-asserted-by":"crossref","first-page":"387.e1","DOI":"10.1016\/j.ajog.2015.09.101","article-title":"Urinary tract infection during pregnancy, angiogenic factor profiles, and risk of preeclampsia","volume":"214","author":"Easter","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.10.003_bib25","doi-asserted-by":"crossref","first-page":"89.e1","DOI":"10.1016\/j.ajog.2016.01.168","article-title":"Sequential plasma angiogenic factors levels in women with suspected preeclampsia","volume":"215","author":"Baltajian","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.10.003_bib26","doi-asserted-by":"crossref","first-page":"359.e1","DOI":"10.1016\/j.ajog.2016.04.002","article-title":"Racial-ethnic differences in midtrimester maternal serum levels of angiogenic and antiangiogenic factors","volume":"215","author":"Yang","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.10.003_bib27","doi-asserted-by":"crossref","first-page":"782.e1","DOI":"10.1016\/j.ajog.2016.07.056","article-title":"In\u00a0vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies","volume":"215","author":"Holme","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.10.003_bib28","doi-asserted-by":"crossref","first-page":"108.e1","DOI":"10.1016\/j.ajog.2015.09.066","article-title":"Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study","volume":"214","author":"Kim","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.10.003_bib29","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1471-0528.2007.01511.x","article-title":"Reduced maternal serum concentrations of angiopoietin-2 in the first trimester precede intrauterine growth restriction associated with placental insufficiency","volume":"114","author":"Wang","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2017.10.003_bib30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1067\/mob.2003.111","article-title":"Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies","volume":"188","author":"Taylor","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.10.003_bib31","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3109\/14767058.2011.625458","article-title":"Mid-pregnancy levels of angiogenic markers as indicators of pathways to preterm delivery","volume":"25","author":"Mijal","year":"2012","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2017.10.003_bib32","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.3109\/14767051003681121","article-title":"An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study","volume":"23","author":"Romero","year":"2010","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2017.10.003_bib33","doi-asserted-by":"crossref","first-page":"594.e1","DOI":"10.1016\/j.ajog.2016.06.007","article-title":"Early pregnancy angiogenic markers and spontaneous abortion: an Odense Child Cohort study","volume":"215","author":"Andersen","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.10.003_bib34","doi-asserted-by":"crossref","first-page":"629.e1","DOI":"10.1016\/j.ajog.2015.11.015","article-title":"Maternal plasma angiogenic index-1 (placental growth factor\/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study","volume":"214","author":"Korzeniewski","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.10.003_bib35","doi-asserted-by":"crossref","first-page":"S9.e1","DOI":"10.1016\/j.ajog.2015.08.003","article-title":"Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity","volume":"213","author":"Redman","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.10.003_bib36","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1016\/j.ajog.2015.08.042","article-title":"Why is placentation abnormal in preeclampsia?","volume":"213","author":"Fisher","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.10.003_bib37","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/35025215","article-title":"Vascular-specific growth factors and blood vessel formation","volume":"407","author":"Yancopoulos","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2017.10.003_bib38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1081\/PRG-120028286","article-title":"Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia","volume":"23","author":"Krauss","year":"2004","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2017.10.003_bib39","doi-asserted-by":"crossref","first-page":"10705","DOI":"10.1073\/pnas.90.22.10705","article-title":"Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor","volume":"90","author":"Kendall","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajog.2017.10.003_bib40","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/j.placenta.2013.10.020","article-title":"Review: the enigmatic role of endoglin in the placenta","volume":"35S","author":"Gregory","year":"2014","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2017.10.003_bib41","doi-asserted-by":"crossref","first-page":"e86273","DOI":"10.1371\/journal.pone.0086273","article-title":"Endoglin is dispensable for vasculogenesis, but required for vascular endothelial growth factor-induced angiogenesis","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2017.10.003_bib42","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1093\/infdis\/jiu346","article-title":"Lopinavir\/ritonavir-based antiretroviral treatment (ART) versus efavirenz-based ART for the prevention of malaria among HIV-infected pregnant women","volume":"210","author":"Natureeba","year":"2014","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ajog.2017.10.003_bib43","doi-asserted-by":"crossref","first-page":"e41934","DOI":"10.1371\/journal.pone.0041934","article-title":"Maternal nutritional status predicts adverse birth outcomes among HIV-infected rural Ugandan women receiving combination antiretroviral therapy","volume":"7","author":"Young","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2017.10.003_bib44","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(14)60932-6","article-title":"International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the Intergrowth-21st Project","volume":"384","author":"Villar","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2017.10.003_bib45","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. 2017. http:\/\/www.R-project.org\/."},{"key":"10.1016\/j.ajog.2017.10.003_bib46","first-page":"1","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J\u00a0Stat Software"},{"key":"10.1016\/j.ajog.2017.10.003_bib47","unstructured":"United Nations Children's Fund and World Health Organization. Low birthweight: country, regional and global estimates. UNICEF New York: 2004."},{"key":"10.1016\/j.ajog.2017.10.003_bib48","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.3109\/14767050902994838","article-title":"A\u00a0subset of patients destined to develop spontaneous preterm labor has an abnormal angiogenic\/anti-angiogenic profile in maternal plasma: evidence in support of pathophysiologic heterogeneity of preterm labor derived from a longitudinal study","volume":"22","author":"Chaiworapongsa","year":"2009","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2017.10.003_bib49","doi-asserted-by":"crossref","first-page":"e0134619","DOI":"10.1371\/journal.pone.0134619","article-title":"Inflammatory and angiogenic factors at mid-pregnancy are associated with spontaneous preterm birth in a cohort of Tanzanian women","volume":"10","author":"McDonald","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2017.10.003_bib50","doi-asserted-by":"crossref","first-page":"509.e1","DOI":"10.1016\/j.ajog.2014.05.032","article-title":"Angiogenic and inflammatory biomarkers in midpregnancy and small-for-gestational-age outcomes in Tanzania","volume":"211","author":"Darling","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.10.003_bib51","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0002-9378(98)70210-8","article-title":"The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in\u00a0healthy nulliparous women. Calcium for Preeclampsia Prevention (CPEP) study group","volume":"179","author":"Joffe","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.10.003_bib52","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/ajh.2009.97","article-title":"Angiopoietin-1\/angiopoietin-2 ratio for prediction of preeclampsia","volume":"22","author":"Bolin","year":"2009","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ajog.2017.10.003_bib53","doi-asserted-by":"crossref","first-page":"174","DOI":"10.5830\/CVJA-2013-029","article-title":"Maternal imbalance between pro-angiogenic and anti-angiogenic factors in HIV-infected women with pre-eclampsia","volume":"24","author":"Govender","year":"2013","journal-title":"Cardiovasc J Afr"},{"key":"10.1016\/j.ajog.2017.10.003_bib54","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1097\/QAD.0b013e328360e9fb","article-title":"Endothelial activation biomarkers increase after HIV-1 acquisition: plasma vascular cell adhesion molecule-1 predicts disease progression","volume":"27","author":"Graham","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.ajog.2017.10.003_bib55","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/1471-2334-13-263","article-title":"A\u00a0prospective study of endothelial activation biomarkers, including plasma angiopoietin-1 and angiopoietin-2, in Kenyan women initiating antiretroviral therapy","volume":"13","author":"Graham","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ajog.2017.10.003_bib56","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1182\/blood-2009-01-198945","article-title":"HIV-1 Tat and heparan sulfate proteoglycan interaction: a novel mechanism of lymphocyte adhesion and migration across the endothelium","volume":"114","author":"Urbinati","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2017.10.003_bib57","doi-asserted-by":"crossref","first-page":"e0153837","DOI":"10.1371\/journal.pone.0153837","article-title":"Circulating fibroblast growth factor-2, HIV-Tat, and vascular endothelial cell growth factor-A in HIV-infected children with renal disease activate Rho-A and Src in cultured renal endothelial cells","volume":"11","author":"Das","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2017.10.003_bib58","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1642-431X(12)60007-2","article-title":"Decreased expression of pigment epithelium derived factor (PEDF), an inhibitor of angiogenesis, in placentas of unexplained stillbirths","volume":"8","author":"Plunkett","year":"2008","journal-title":"Reprod Biol"},{"key":"10.1016\/j.ajog.2017.10.003_bib59","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s10995-016-2220-9","article-title":"Gestational weight gain and maternal and neonatal outcomes in underweight pregnant women: a population-based historical cohort study","volume":"21","author":"Gavard","year":"2017","journal-title":"Matern Child Health J"},{"key":"10.1016\/j.ajog.2017.10.003_bib60","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/QAI.0000000000000281","article-title":"Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir\/ritonavir- or efavirenz-based antiretroviral therapy","volume":"67","author":"Koss","year":"2014","journal-title":"J\u00a0Acquir Immune Defic Syndr (1999)"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937817311857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937817311857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:18:29Z","timestamp":1757589509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937817311857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0002937817311857"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2017.10.003","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered angiogenesis as a common mechanism underlying preterm birth, small for gestational age, and stillbirth in women living with HIV","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2017.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}